Cargando…

Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2

To inform seroepidemiological studies, we characterized the IgG‐ responses in COVID‐19 patients against the two major SARS‐CoV‐2 viral proteins, spike (S) and nucleocapsid (N). We tested 70 COVID‐19 sera collected up to 85 days post‐symptom onset and 230 non‐COVID‐19 sera, including 27 SARS sera fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Cheng, Ling, Shiman, Qiu, Minshan, Deng, Zhenxuan, Chen, Liping, Zhu, Airu, Chen, Yi, Liu, Yong, Lin, Xia, Lin, Fangmei, Wu, Qiubao, Shen, Lihan, Ye, Feng, Liu, Xiaoqing, Li, Yimin, Zhao, Jincun, Yang, Zifeng, Cowling, Benjamin J., Webby, Richard, Zanin, Mark, Wong, Sook‐San
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461388/ https://www.ncbi.nlm.nih.gov/pubmed/32844604 http://dx.doi.org/10.1111/irv.12798

Ejemplares similares

SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients
por: Lei, Hui, et al.
Publicado: (2020)

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
por: Rikhtegaran Tehrani, Zahra, et al.
Publicado: (2020)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

The public health response to the COVID-19 outbreak in mainland China: a narrative review
por: Zanin, Mark, et al.
Publicado: (2020)

Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020
por: Xiao, Cheng, et al.
Publicado: (2021)

The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
por: Ma, Qinhai, et al.
Publicado: (2020)

Antibody Responsiveness to Influenza: What Drives It?
por: Lin, Xia, et al.
Publicado: (2021)

Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy
por: Zhao, Jin, et al.
Publicado: (2020)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Using discrete event simulation to optimize nucleic acid testing process for coronavirus disease 2019 (COVID-19)
por: Guan, Wenda, et al.
Publicado: (2022)

Structural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral Target
por: Lin, Shing-Yen, et al.
Publicado: (2014)

The impact of pre‐existing influenza antibodies and inflammatory status on the influenza vaccine responses in older adults
por: Kang, Min, et al.
Publicado: (2023)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021)

HLA-A(∗)0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins
por: Tsao, Yeou-Ping, et al.
Publicado: (2006)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines
por: Wong, Sook-San, et al.
Publicado: (2017)

Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19
por: Chen, Liping, et al.
Publicado: (2022)

Analysis of pathological changes in the epithelium in COVID-19 patient airways
por: Yin, Wenguang, et al.
Publicado: (2021)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
por: Dörschug, Anja, et al.
Publicado: (2021)

Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
por: Forcelloni, Sergio, et al.
Publicado: (2021)

Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests
por: Takano, Tomomi, et al.
Publicado: (2014)

Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips
por: Liu, Dan, et al.
Publicado: (2021)

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America
por: Franco-Muñoz, Carlos, et al.
Publicado: (2020)

Computational studies of the dynamics of SARS-CoV-2 spike, membrane, and nucleocapsid proteins
por: Dutta, Mandira, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine
por: Asmar, Imad, et al.
Publicado: (2023)

Engineered recombinant protein products of the avian paramyxovirus type-1 nucleocapsid and phosphoprotein genes for serological diagnosis
por: Zhao, Na, et al.
Publicado: (2018)

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS
por: Saijo, Masayuki, et al.
Publicado: (2005)

Serological detection of antibodies to the SARS-CoV-2 nucleocapsid protein from dried blood spots
por: Dhar, Arko, et al.
Publicado: (2022)

SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama
por: Díaz, Yamilka, et al.
Publicado: (2021)

The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus
por: Mu, Feng, et al.
Publicado: (2008)

Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
por: Lee, Eunok, et al.
Publicado: (2021)

Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
por: Dangi, Tanushree, et al.
Publicado: (2021)

Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation
por: Youn, Young-Jin, et al.
Publicado: (2021)

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022)

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

Susceptibility of SARS COV-2 nucleocapsid and spike proteins to reactive oxygen species and role in inflammation
por: Pavlova, Elitsa, et al.
Publicado: (2023)

Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins
por: Zhang, Pingping, et al.
Publicado: (2020)

Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid protein
por: Chen, I.-Jung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_avlimr162u793evmdmebh4db6f